EriVan Bio is a biotechnology company, established to innovate and deliver products and services related to exosome technology for molecular and cell biology research and therapeutic purposes, particularly regenerative medicine and drug delivery. EriVan Bio is focused on the development of a broad pipeline of novel and targeted biomolecules to address different unmet medical needs.
EriVan Bio works mainly in the regeneration and drug delivery field for unmet medical needs. Moreover, there is a potential for exosomes to be used as targeted delivery vehicles of therapeutic molecules to the target organ.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 12085 Research Dr, Alachua,florida 32615,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://erivanbio.com
- Keywords
- related to exosome technology for molecular and cell biology research and therapeutic purposes.
- HQ
- Alachua, Florida
Erivan Bio Questions
Erivan Bio's website is https://erivanbio.com
Erivan Bio's LinkedIn profile is https://www.linkedin.com/company/erivanbio
Erivan Bio has
4 employees.
View email and phone details for 4
employees at Erivan Bio.
Erivan Bio's industry is
Biotechnology Research
Erivan Bio's top competitors are
Sivec Biotechnologies Llc,
Biotility,
Vaxess Technologies,
Informuta,
5dg Therapeutics,
New Orleans Bioinnovation Center,
Evergen,
Anvil Diagnostics,
Vocxi Health,
42bio, Inc..
Erivan Bio's categories are Biotechnology Research
Erivan Bio's founding year is 2018
